Info
Ownership

Carl Dambkowski - Insider Trading & Ownership

Location: 221 Crescent St., Building 17, Suite 102 B, Waltham, MA
Summary: The estimated net worth of Carl Dambkowski is at least $11.1M dollars as of July 3, 2025. Carl Dambkowski is the Chief Medical Officer of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $11.1M.
Signature: /s/ Matthew Batters, as attorney-in-fact for Carl Dambkowski
All Insider Reports: All Insider Reports

Ownership of Carl Dambkowski

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
APGE	Apogee Therapeutics, Inc.	Chief Medical Officer	$11.1M	-$3.09M	-21.8%	Jul 2, 2025
ORKA	Oruka Therapeutics, Inc.	Director				Jun 2, 2025

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Carl Dambkowski:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-4.05%	-$455K	45.09	-10.1K	239K	7/2/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Options Exercise	+3.05%	$168K	22.86	+7.37K	249K	7/2/2025	Direct
APGE	Apogee Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-4.3%	$0	0.00	-7.37K	164K	7/2/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-1.11%	-$101K	36.96	-2.73K	242K	6/4/2025	Direct
ORKA	Oruka Therapeutics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+17.5K	17.5K	6/2/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-1.1%	-$97.4K	35.75	-2.73K	244K	5/7/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-1.54%	-$140K	36.22	-3.86K	247K	4/2/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-0.63%	-$48.5K	30.48	-1.59K	251K	3/5/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-1.37%	-$143K	40.69	-3.52K	253K	2/5/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Options Exercise	+0.31%	$18.2K	22.86	+795	256K	2/5/2025	Direct
APGE	Apogee Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-0.46%	$0	0.00	-795	171K	2/5/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-1.57%	-$192K	46.94	-4.09K	255K	1/2/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Options Exercise	+0.53%	$31.1K	22.86	+1.36K	259K	1/2/2025	Direct
APGE	Apogee Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-0.78%	$0	0.00	-1.36K	172K	1/2/2025	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-1.73%	-$221K	48.76	-4.54K	258K	12/11/2024	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Options Exercise	+0.7%	$41.5K	22.86	+1.82K	263K	12/11/2024	Direct
APGE	Apogee Therapeutics, Inc.	Stock Option (Right to Buy)	Options Exercise	-1.04%	$0	0.00	-1.82K	174K	12/11/2024	Direct
APGE	Apogee Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+125K	125K	12/9/2024	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-2.49%	-$307K	46.07	-6.67K	261K	12/4/2024	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-2.43%	-$394K	59.12	-6.67K	267K	11/6/2024	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-2.37%	-$375K	56.26	-6.67K	274K	10/2/2024	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-2.32%	-$317K	47.56	-6.67K	281K	9/4/2024	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-2.49%	-$298K	40.67	-7.34K	287K	8/7/2024	Direct
APGE	Apogee Therapeutics, Inc.	Common Stock	Sale	-1.99%	-$225K	37.60	-6K	295K	7/3/2024	Direct
APGE	Apogee Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+175K	175K	12/18/2023	Direct

Previous1Next

Showing 1 to 25 of 25 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.